Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multi-modality approaches to the management of esophageal cancer.
|Original language||English (US)|
|Number of pages||10|
|Journal||JNCCN Journal of the National Comprehensive Cancer Network|
|State||Published - Oct 2008|
- Esophageal cancer
ASJC Scopus subject areas